Select Bibliography

Filter by any of these (after searching):

CALGB-30610

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 10 items

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - JAMA Oncol - 2017

Manuscript - Secondary-not-in-original - Meta-Analysis - Health Outcomes - CALGB-30607 , CALGB-30610 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-70501 , CALGB-70604 , CALGB-80405 , CALGB-90401

High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538

Bogart, Jeffrey , Wang, Xiaofei , Masters, Gregory , Gao, Junheng ... - - J Clin Oncol - 2023

Manuscript - Primary - Primary - Respiratory - CALGB-30610

Impact of Stratification Factors on Outcomes in Limited-Stage Small Cell Lung Cancer: Analysis of CALGB 30610 (Alliance)/RTOG 0538

Bogart, Jeffrey , Wang, Xiaofei , Masters, Gregory , Gao, Junheng ... - ESMO - Ann Oncol - 2022

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-30610

Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538

Bogart, Jeffrey , Wang, Xiaofei , Masters, Gregory , Gao, Junheng ... - - Lung Cancer - 2021

Manuscript - Secondary - Primary - Respiratory - CALGB-30610

Phase III Comparison of High Dose Once-Daily (QD) Thoracic Radiotherapy (TRT) with Standard Twice-Daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance) / RTOG 0538

Bogart, Jeffrey , Wang, Xiaofei , Masters, Gregory , Gao, Junheng ... - ASCO - J Clin Oncol - 2021

Abstract - Primary - Primary - Respiratory - CALGB-30610

Mature outcomes of 61.2 Gy concomitant boost (CB) thoracic radiotherapy (TRT) in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance) / RTOG 0538

Bogart, Jeffrey , Wang, Xiaofei , Masters, Gregory , Gao, Junheng ... - ASTRO - International Journal of Radiation Oncology, Biology, & Physics - 2021

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-30610

Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on the experimental thoracic radiotherapy (TRT) arms of CALGB 30610 (Alliance) / RTOG 0538

Bogart, Jeffrey , Wang, Xiaofei , Masters, Gregory , Zhu, Han ... - ESMO - Ann Oncol - 2019

Abstract - Secondary - Primary - Respiratory - CALGB-30610

Prognostic Factors in Limited-Stage Small Cell Lung Cancer

Farris, Michael K. , Mix, Michael D. , Wang, Xiaofei ... - - JAMA Netw Open - 2024

Manuscript - Secondary-not-in-original - Primary - Respiratory - CALGB-30610

Prognostic Factors in Limited-Stage Small Cell Lung Cancer (LSCLC) : Secondary Analysis of CALGB 30610 (Alliance)/RTOG 0538

Farris, Michael , Mix, Michael , Wang, Xiaofei , Jaszewski, Brandy ... - IASLC (WCLC) - J Thoracic Oncol - 2023

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-30610

Comparison of quality of life in patients randomized to high-dose once daily (QD) thoracic radiotherapy (TRT) with standard twice daily (BID) TRT in limited stage small cell lung cancer (LS-SCLC) on CALGB 30610 (CALGB 70702) Alliance

Ganti, Apar K. , Dueck, Amylou C. , Fruth, Briant , Rimner, Andreas ... - ASCO - J Clin Oncol - 2022

Abstract - Secondary - Primary - Health Outcomes - CALGB-70702 , CALGB-30610